top of page
Newsroom
Press Releases and Announcements
Addiction Stigma in America: How Public Knowledge Shapes Attitudes Toward Recovery
The Addiction Policy Forum and Gallup released Addiction Stigma in America: How Public Knowledge Shapes Attitudes Toward Recovery, featuring findings from a nationally representative study examining Americans’ addiction literacy and how it influences stigma, attitudes toward individuals in recovery, and support for public health policies. The report is also available on Gallup's website. The study included a nationally representative sample of 5,097 U.S. adults surveyed throu
Jun 2
1 in 4 U.S. Adults Don’t Recognize Addiction as a Health Condition
New Addiction Policy Forum and Gallup Study Released Findings from a nationally representative study show that nearly 1 in 4 U.S. adults (23%) either disagree or do not know that addiction is a health condition. Individuals who did not recognize addiction as a health condition were significantly less likely to believe substance use disorders (SUDs) are treatable by healthcare professionals, that early intervention works, or that medications are effective treatments to treat a
Jun 1
Cannabis Use Trends, Risks, and the Evolving Policy Landscape with Dr. Rosalie Pacula
Cannabis access has accelerated globally and across the United States, creating substantial variation in regulatory systems, product availability, potency limits, commercialization practices, and public health risks. In this Ask the Expert video, Dr. Rosalie Liccardo Pacula, Professor and Elizabeth Garrett Chair in Health Policy, Economics & Law in the Sol Price School of Public Policy at the University of Southern California, examines the evolving policy landscape of cannabi
May 12
Screening for Cannabis Use Disorder and Effective Tools to Educate Youth on the Risks with Dr. Bonnie Halpern-Felsher
As cannabis products have evolved, so too have the risks—especially for young people. Today’s cannabis products contain far higher levels of THC than in previous decades, with some products reaching up to 80-90% THC. This shift is raising concerns due to its association with increased risk of addiction, mental health challenges, and psychosis. In this Ask the Expert explainer, Dr. Bonnie Halpern-Felsher, Professor of Pediatrics and Director of the Stanford REACH Lab at Stanfo
Apr 27
Addiction Policy Forum Launches Cannabis Use Disorder Prevention and Awareness Week
The Addiction Policy Forum launched the inaugural Cannabis Use Disorder Prevention and Awareness Week, April 15-22. The national educational initiative aims to increase public understanding of cannabis use disorder, symptoms of cannabis use disorder, highlight emerging health risks, and promote prevention efforts. As cannabis use continues to rise across the United States, public perception of its risks remains low. However, research shows that an estimated 20.6 million peopl
Apr 13
Research and Science Highlights
Alcohol Remains the Primary Driver of Treatment Admissions in the U.S., followed by Methamphetamines and Heroin
A recent report from the Substance Abuse and Mental Health Services Administration (SAMHSA) provides a comprehensive look at substance use disorder (SUD) treatment across the United States, including who is entering treatment, what substances are most commonly involved, and what services are being utilized. Drawing on data from the Treatment Episode Data Set (TEDS), the annual report captures admissions and discharges among individuals ages 12 and older receiving treatment a
Apr 7
Study Finds Association Between Chronic Cannabis Use and Cardiovascular Dysfunction
In a study published in JAMA Cardiology , researchers found chronic cannabis use—whether through smoking or THC-infused edibles—is associated with impaired vascular function, even among young and otherwise healthy adults. Healthy vascular function allows blood vessels to dilate properly, deliver oxygen efficiently, and help regulate key processes within the circulatory system. When vascular function is impaired, blood vessels are less able to expand, which can reduce blood fl
Mar 30
Treating Depression Early in Treatment May Improve Methamphetamine Use Disorder Outcomes
Methamphetamine use disorder (MUD) continues to pose a growing public health challenge in the United States. Despite rising rates of use and overdose deaths, there are currently no FDA-approved medications for treating MUD. Prior studies have shown that naltrexone (used to treat opioid and alcohol use disorders) and bupropion (an antidepressant) have independently been effective in MUD treatment. In a 2021 landmark clinical trial (ADAPT-2), researchers found that combining t
Mar 24
Adolescent Cannabis Use Associated With Increased Risk of Psychiatric Disorders
A new study published in JAMA Health Forum found that adolescent cannabis use was associated with an increased risk of developing psychotic, bipolar, depressive, and anxiety disorders by young adulthood. The study included over 400,000 adolescents ages 13 to 17 who were universally screened for past-year cannabis use during routine pediatric visits between 2016 and 2023. Participants were followed through age 25, and researchers examined clinician-diagnosed psychiatric disor
Mar 4
Methadone Treatment for Opioid Use Disorder has Increased, but Access Gaps Persist
Despite growth in the use of medications used to treat opioid use disorder (OUD) – including methadone, buprenorphine, and naltrexone – most people with OUD in the United States still do not receive medication. National estimates show only 25% of individuals with OUD receive medications for OUD (MOUD), underscoring a persistent gap between need and access. Research published in JAMA Health Forum found methadone treatment among Medicaid enrollees increased substantially ove
Feb 26
bottom of page